Literature DB >> 35602406

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

Jeremiah Bernier-Latmani1, Christophe Cisarovsky1, Samantha Mahfoud1, Simone Ragusa1, Isabelle Dupanloup2, David Barras1,2, François Renevey3, Sina Nassiri4,2, Pascale Anderle2, Mario Leonardo Squadrito4, Stefanie Siegert3, Suzel Davanture1, Alejandra González-Loyola1, Nadine Fournier2, Sanjiv A Luther3, Rui Benedito5, Philippe Valet6, Bin Zhou7, Michele De Palma4, Mauro Delorenzi1,2, Christine Sempoux8, Tatiana V Petrova1,4.   

Abstract

Stem and progenitor cells residing in the intestinal crypts drive the majority of colorectal cancers (CRCs), yet vascular contribution to this niche remains largely unexplored. VEGFA is a key driver of physiological and tumor angiogenesis. Accordingly, current anti-angiogenic cancer therapies target the VEGFA pathway. Here we report that in CRC expansion of the stem/progenitor pool in intestinal crypts requires VEGFA-independent growth and remodeling of blood vessels. Epithelial transformation induced expression of the endothelial peptide apelin, directs migration of distant venous endothelial cells towards progenitor niche vessels ensuring optimal perfusion. In the absence of apelin, loss of injury-inducible PROX1+ epithelial progenitors inhibited both incipient and advanced intestinal tumor growth. Our results establish fundamental principles for the reciprocal communication between vasculature and the intestinal progenitor niche and provide a mechanism for resistance to VEGFA-targeting drugs in CRCs.

Entities:  

Year:  2022        PMID: 35602406      PMCID: PMC7612746          DOI: 10.1038/s44161-022-00061-5

Source DB:  PubMed          Journal:  Nat Cardiovasc Res        ISSN: 2731-0590


  85 in total

1.  Biology of the apelin-APJ axis in vascular formation.

Authors:  Hiroyasu Kidoya; Nobuyuki Takakura
Journal:  J Biochem       Date:  2012-06-28       Impact factor: 3.387

2.  Studies on blood flow distribution and countercurrent exchange in the small intestine.

Authors:  O Lundgren
Journal:  Acta Physiol Scand Suppl       Date:  1967

3.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

4.  Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.

Authors:  Rachel S Kerr; Sharon Love; Eva Segelov; Elaine Johnstone; Beverly Falcon; Peter Hewett; Andrew Weaver; David Church; Claire Scudder; Sarah Pearson; Patrick Julier; Francesco Pezzella; Ian Tomlinson; Enric Domingo; David J Kerr
Journal:  Lancet Oncol       Date:  2016-09-19       Impact factor: 41.316

5.  Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice.

Authors:  Simone Ragusa; Borja Prat-Luri; Alejandra González-Loyola; Sina Nassiri; Mario Leonardo Squadrito; Alan Guichard; Sabrina Cavin; Nikolce Gjorevski; David Barras; Giancarlo Marra; Matthias P Lutolf; Jean Perentes; Emily Corse; Roberta Bianchi; Laureline Wetterwald; Jaeryung Kim; Guillermo Oliver; Mauro Delorenzi; Michele De Palma; Tatiana V Petrova
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

6.  The Molecular Signatures Database (MSigDB) hallmark gene set collection.

Authors:  Arthur Liberzon; Chet Birger; Helga Thorvaldsdóttir; Mahmoud Ghandi; Jill P Mesirov; Pablo Tamayo
Journal:  Cell Syst       Date:  2015-12-23       Impact factor: 10.304

7.  Inhibition of VEGF-A prevents the angiogenic switch and results in increased survival of Apc+/min mice.

Authors:  Nina Korsisaari; Ian M Kasman; William F Forrest; Navneet Pal; Wei Bai; Germaine Fuh; Franklin V Peale; Ron Smits; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

8.  A computational tool for quantitative analysis of vascular networks.

Authors:  Enrique Zudaire; Laure Gambardella; Christopher Kurcz; Sonja Vermeren
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Apelin inhibition prevents resistance and metastasis associated with anti-angiogenic therapy.

Authors:  Iris Uribesalgo; David Hoffmann; Yin Zhang; Anoop Kavirayani; Jelena Lazovic; Judit Berta; Maria Novatchkova; Tsung-Pin Pai; Reiner A Wimmer; Viktória László; Daniel Schramek; Rezaul Karim; Luigi Tortola; Sumit Deswal; Lisa Haas; Johannes Zuber; Miklós Szűcs; Keiji Kuba; Balazs Dome; Yihai Cao; Bernhard J Haubner; Josef M Penninger
Journal:  EMBO Mol Med       Date:  2019-06-24       Impact factor: 12.137

View more
  1 in total

1.  ADAMTS18+ villus tip telocytes maintain a polarized VEGFA signaling domain and fenestrations in nutrient-absorbing intestinal blood vessels.

Authors:  Jeremiah Bernier-Latmani; Cristina Mauri; Rachel Marcone; François Renevey; Stephan Durot; Liqun He; Michael Vanlandewijck; Catherine Maclachlan; Suzel Davanture; Nicola Zamboni; Graham W Knott; Sanjiv A Luther; Christer Betsholtz; Mauro Delorenzi; Cathrin Brisken; Tatiana V Petrova
Journal:  Nat Commun       Date:  2022-07-09       Impact factor: 17.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.